CCM
MDT icon

Channing Capital Management’s Medtronic MDT Stock Holding History

Channing Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82,577
Closed -$6.6M – 117
2024
Q4 		$6.6M Sell
82,577
-16,855
-17% -$1.46M 0.18% 95
2024
Q3 		$8.95M Buy
99,432
+13,588
+16% +$1.14M 0.23% 76
2024
Q2 		$6.76M Buy
85,844
+12,494
+17% +$1.02M 0.19% 93
2024
Q1 		$6.39M Sell
73,350
-6,901
-9% -$589K 0.17% 98
2023
Q4 		$6.61M Buy
80,251
+5,532
+7% +$422K 0.2% 91
2023
Q3 		$5.85M Buy
74,719
+21
+0% +$1.76K 0.19% 89
2023
Q2 		$6.58M Sell
74,698
-13,261
-15% -$1.14M 0.2% 88
2023
Q1 		$7.09M Sell
87,959
-32,622
-27% -$2.66M 0.23% 83
2022
Q4 		$9.37M Buy
120,581
+24,420
+25% +$1.98M 0.3% 86
2022
Q3 		$7.76M Buy
96,161
+5,083
+6% +$457K 0.27% 84
2022
Q2 		$8.17M Buy
91,078
+9,000
+11% +$912K 0.27% 79
2022
Q1 		$9.11M Buy
82,078
+9,882
+14% +$1.04M 0.27% 83
2021
Q4 		$7.47M Buy
+72,196
New +$8.36M 0.21% 96

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Channing Capital Management's MDT Position: Q1 2025 in Review

Channing Capital Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 82,577 shares — an estimated $6.6M sold.

Channing Capital Management first reported a position in MDT in Q4 2021 and held it in 13 quarters. The position peaked at $9.37M in Q4 2022. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Channing Capital Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Channing Capital Management sold 82,577 Medtronic shares in Q1 2025, an estimated $6.6M.
  • Channing Capital Management first reported a position in Medtronic in Q4 2021 and held it in 13 quarters.
  • Channing Capital Management's Medtronic position peaked at $9.37M in Q4 2022.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Channing Capital Management's 13F filing for Q1 2025, filed 14 May 2025.